Company intelligence / Profile preview

ABBio

Dundee, Scotland, United Kingdom

Ownership: Private
Employees: ~3
Development stage: Other

Overview

ABBio develops distinctive antibodies for various diseases, with notable work on specialized p53 antibodies. The company remains small and research-focused, with no disclosed clinical results or marketed products yet.

Therapeutic areas: Other
Modalities: Antibody
Industry: Biotech

Partnerships

Innova Partnerships (investor/supporter)

Beyond the preview

Go deeper on ABBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABBio.

Explore the full profile